HCA Holdings Inc (HCA): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

HCA Holdings ( HCA) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.1%. By the end of trading, HCA Holdings rose 98 cents (3.3%) to $30.62 on heavy volume. Throughout the day, five million shares of HCA Holdings exchanged hands as compared to its average daily volume of 2.3 million shares. The stock ranged in a price between $29.91-$30.99 after having opened the day at $30.13 as compared to the previous trading day's close of $29.64. Other companies within the Health Care sector that increased today were: Kips Bay Medical ( KIPS), up 26.3%, Columbia Laboratories ( CBRX), up 17.5%, Amyris ( AMRS), up 16.4%, and Oxygen Biotherapeutics ( OXBT), up 16.3%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $13.55 billion and is part of the health services industry. The company has a P/E ratio of 5.4, above the average health services industry P/E ratio of 5.1 and below the S&P 500 P/E ratio of 17.7. Shares are up 34.5% year to date as of the close of trading on Tuesday. Currently there are 16 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and two rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and feeble growth in its earnings per share.

On the negative front, United Therapeutics Corporation ( UTHR), down 15.6%, ARCA biopharma ( ABIO), down 13.3%, MEI Pharma ( MEIP), down 11.9%, and Arrhythmia Research Technology ( HRT), down 10%, were all laggards within the health care sector with Onyx Pharmaceuticals ( ONXX) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%